Aishwarya Arora

• Drove product strategy and development for an AI-based Pap smear screening platform to support early cervical cancer detection. • Defined AI use cases and product requirements through clinician and laboratory insights. • Navigated multi-country regulatory pathways and informed global strategy through targeted market analysis. • Built KOL engagement and represented the platform at international scientific congresses.

• Led strategic growth across 10+ global alliances, expanding custom reagents portfolio across pharma and CRO's. • Converted high-value opportunities, improving pipeline quality across clinical and research stakeholders. • Coordinated cross-functional execution, reducing delivery timelines by 15% in clinical and R&D workflows • Strengthened market positioning through integration into clinical research and translational workflows.

• Managed strategic accounts across Forbes-ranked academic institutions and pharma clients, engaging medical affairs stakeholders. • Improved onboarding and accelerated client activation across accounts. • Streamlined the commercial cycle across CRO and pharma accounts via stakeholder coordination, reducing deal turnaround time. • Expanded accounts through solution selling, generating $75K+ incremental revenue.

• Led adoption of custom solutions across biopharma clients, supporting R&D and translational research applications. • Improved workflow efficiency across clinical and research environments through technical optimization. • Coordinated execution across stakeholders via cross-functional collaboration. • Represented organization at global conferences, strengthening industry visibility and market presence.

• Analyzed 300+ research papers and reports, driving insight-led decisions and revenue opportunities. • Identified unmet needs, shaping client market entry and prioritization. • Tracked competitors and trends, enabling faster strategic shifts. • Translated scientific data into actionable business insights. • Identified emerging trends early, supporting opportunity capture.